For the Quarter Ending March 2026
Ketoconazole Prices in North America
- In United States, the Ketoconazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging domestic feedstock costs.
- The Ketoconazole Production Cost Trend increased in March 2026 as producer prices rose 4.0% year-over-year across markets.
- Consumer prices increased 3.3% year-over-year in March 2026, elevating logistics and distribution expenses for the Ketoconazole Price Index.
- The Ketoconazole Demand Outlook remained robust during March 2026, supported by retail sales growing 4.0% year-over-year nationwide.
- A stable 4.3% unemployment rate in March 2026 sustained prescription access, strengthening February 2026 pharmaceutical preparation imports.
- Industrial production grew 0.7% year-over-year in March 2026, while the Manufacturing Index expanded, tightening domestic supply chains.
- Consumer confidence reached 91.8 in March 2026, while United States benzene export volumes plummeted significantly during February 2026.
- The Ketoconazole Price Forecast indicated upward pressure in March 2026 as domestic propylene availability tightened across petrochemical units.
Why did the price of Ketoconazole change in March 2026 in North America?
- Global benzene feedstock prices surged in March 2026 amid severe supply disruptions and escalating geopolitical tensions.
- United States propylene contract prices strengthened through March 2026 amid tightening domestic chemical feedstock availability conditions.
- United States pharmaceutical preparation imports strengthened in February 2026, reflecting robust downstream healthcare sector consumption trends.
Ketoconazole Prices in APAC
- In China, the Ketoconazole Price Index rose quarter-over-quarter in Q1 2026, driven by strengthened domestic imidazole feedstock costs.
- The Ketoconazole Production Cost Trend increased in March 2026 as the PPI grew by 0.5%.
- The Ketoconazole Demand Outlook stabilized in March 2026, supported by a mild 1.0% CPI increase.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, which softened discretionary purchases.
- Consumer confidence hit 91.6 in February 2026, which dampened the Ketoconazole Price Forecast for cosmetics.
- Industrial production grew 5.7% in March 2026, which ensured robust raw material supply for synthesis.
- The Manufacturing Index expanded in March 2026, which indicated robust activity across fine chemical sectors.
- Domestic pharmaceutical API inventories tightened while export volumes to international markets surged during Q1 2026.
- Piperazine raw material costs fluctuated in Q1 2026 amid stringent environmental restrictions on precursor chemicals.
Why did the price of Ketoconazole change in March 2026 in APAC?
- Imidazole feedstock costs strengthened and intermediate inventories plummeted across the domestic region in Q1 2026.
- Pharmaceutical API export volumes surged to international markets across the APAC region in Q1 2026.
- Natural gas prices stabilized in Q1 2026, providing consistent utility costs for regional chemical synthesis.
Ketoconazole Prices in Europe
- In Germany, the Ketoconazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging energy costs.
- The Ketoconazole Production Cost Trend increased in March 2026 as inflation reached 2.7 percent year-over-year.
- Producer prices declined by -0.2 percent in March 2026, easing upstream fine chemical synthesis costs.
- The Ketoconazole Demand Outlook strengthened in March 2026 as the Manufacturing Index expanded for compounding.
- Industrial production remained stagnant at 0.0 percent in February 2026, reflecting flat chemical manufacturing activity.
- Retail sales grew 0.7 percent in February 2026, supporting steady consumer purchasing of health products.
- A stable 4.2 percent unemployment rate in February 2026 sustained baseline consumer spending for healthcare.
- The Ketoconazole Price Forecast remained cautious in March 2026 as consumer confidence hit -24.7 index.
Why did the price of Ketoconazole change in March 2026 in Europe?
- Brent crude oil costs spiked in March 2026 following escalated Middle Eastern geopolitical trade conflicts.
- Spring cracker maintenance impacted domestic benzene inventory economics in March 2026, tightening precursor material availability.
- Domestic demand for active pharmaceutical ingredients stabilized in February 2026, supported by federal supply funding.
For the Quarter Ending December 2025
Ketoconazole Prices in North America
- In United States, Ketoconazole Price Index rose in Q4 2025, driven by increasing production costs and robust consumer demand.
- Ketoconazole production costs increased in Q4 2025, due to rising Henry Hub natural gas prices in December 2025.
- Producer Price Index (PPI) rose 3.0% year-over-year in November 2025, indicating higher input costs for Ketoconazole.
- Ketoconazole demand outlook strengthened in Q4 2025, supported by a 3.3% year-over-year rise in retail sales.
- Overall industrial production in the United States moderately strengthened in December 2025, increasing 2.0% year-over-year.
- A 4.4% unemployment rate in December 2025 supported consumer spending on healthcare, boosting Ketoconazole demand.
- US crude oil inventories remained slightly below the five-year average in December 2025, impacting feedstock availability.
- Potential labor disruptions at US Gulf and East Coast ports in 2025 could pressure Ketoconazole shipping costs.
Why did the price of Ketoconazole change in December 2025 in North America?
- Rising Henry Hub natural gas spot prices in December 2025 increased Ketoconazole production costs.
- A 2.7% year-over-year Consumer Price Index increase in December 2025 reflected broader inflationary pressures.
- Strong retail sales, up 3.3% year-over-year in November 2025, supported Ketoconazole product demand.
Ketoconazole Prices in APAC
- In China, the Ketoconazole Price Index fell quarter-over-quarter in Q4 2025, influenced by decreasing producer input costs.
- Ketoconazole production costs declined in December 2025, as the Producer Price Index fell by 1.9% year-over-year.
- Demand for Ketoconazole faced headwinds in December 2025 due to subdued retail sales growth of 0.9% year-over-year.
- China's pharmaceutical market experienced robust growth in 2025, driven by aging population and healthcare demands.
- Industrial production strengthened by 5.2% year-over-year in December 2025, supporting Ketoconazole supply.
- Chemical product exports and imports from China increased in November 2025, impacting Ketoconazole trade flows.
- Nationwide ex-factory LNG prices in China declined year-on-year in 2025, contributing to lower energy costs.
- Consumer price inflation remained low at 0.8% year-over-year in December 2025, indicating stable consumer prices.
Why did the price of Ketoconazole change in December 2025 in APAC?
- Producer Price Index declined by 1.9% year-over-year in December 2025, reducing Ketoconazole production costs.
- Retail sales growth was subdued at 0.9% year-over-year in December 2025, impacting OTC Ketoconazole demand.
- Industrial production strengthened by 5.2% year-over-year in December 2025, supporting overall supply.
Ketoconazole Prices in Europe
- In Germany, the Ketoconazole Price Index fell in Q4 2025, influenced by declining producer prices in December 2025.
- Ketoconazole production costs remained elevated in Q4 2025 due to persistently high European gas prices and raw material costs.
- The Ketoconazole demand outlook was mixed, with steady pharmaceutical demand offsetting weaker consumer confidence in December 2025.
- Consumer Price Index rose 1.8% year-over-year in December 2025, increasing operational costs for Ketoconazole manufacturers.
- Industrial production grew 0.8% year-over-year in October 2025, supporting stable supply chain infrastructure.
- Retail sales increased 1.1% year-over-year in November 2025, supporting demand for over-the-counter Ketoconazole products.
- The Manufacturing Index indicated contracting economic activity in December 2025, affecting general industrial inputs.
- Weak domestic and export orders for the German chemical industry in Q4 2025 indicated rising import pressures.
Why did the price of Ketoconazole change in December 2025 in Europe?
- Producer Price Index declined 2.5% in December 2025, lowering Ketoconazole manufacturing input costs.
- Elevated raw material costs and high European natural gas prices in Q4 2025 sustained production.
- Consumer confidence was -17.5 in December 2025, indicating reduced spending on discretionary items.
For the Quarter Ending September 2025
Ketoconazole Prices in North America
- In United States, the Ketoconazole Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs and supply constraints.
- Ketoconazole production costs increased in Q3 2025, influenced by a 2.6% year-over-year PPI rise in August 2025.
- General inflation, with CPI up 3.0% year-over-year in September 2025, raised operational costs for manufacturers.
- Pharmaceutical sector demand for Ketoconazole experienced a resurgence in Q3 2025.
- Energy costs, including Henry Hub natural gas and industrial electricity, rose in September 2025, increasing manufacturing expenses.
- US chemical production declined in Q3 2025, exacerbated by 0.1% year-over-year industrial production growth.
- Manufacturers' inventories contracted in Q3 2025 due to accelerating destocking, affecting Ketoconazole availability.
- Strong retail sales, up 5.42% year-over-year in September 2025, supported demand for over-the-counter Ketoconazole products.
- Consumer confidence declined to 94.2 in September 2025, tempering discretionary spending on health products.
Why did the price of Ketoconazole change in September 2025 in North America?
- Rising production costs, evidenced by a 2.6% PPI increase in August 2025, directly impacted Ketoconazole pricing.
- Supply constraints from declining US chemical production and contracting inventories tightened Ketoconazole availability.
- Increased energy costs in September 2025, alongside a 3.0% CPI rise, elevated manufacturing and operational expenses.
Ketoconazole Prices in APAC
- In China, the Ketoconazole Price Index remained stable quarter-over-quarter in Q3 2025, despite a -0.3% CPI YoY in September 2025.
- Ketoconazole production costs trended lower in Q3 2025, supported by a -2.3% PPI YoY in September 2025.
- Demand for over-the-counter Ketoconazole was supported by 3.0% retail sales growth in September 2025.
- China's pharmaceutical market demand strengthened in Q3 2025, driven by rising healthcare needs.
- Raw material inventories for manufacturing declined in July and August 2025, tightening supply.
- A contracting Manufacturing Index in September 2025 indicated a slowdown in overall economic activity.
- Industrial production increased by 6.5% year-on-year in September 2025, supporting economic stability.
- The Ketoconazole Price Forecast suggests stability, balancing lower production costs against trade tensions.
Why did the price of Ketoconazole change in September 2025 in APAC?
- Production costs decreased in Q3 2025, driven by declining natural gas prices and a -2.3% PPI YoY.
- Retail sales grew 3.0% in September 2025, supporting demand for over-the-counter Ketoconazole products.
- New US tariffs on pharmaceutical imports from August 2025 influenced trade dynamics and import costs.
Ketoconazole Prices in Europe
- In Germany, the Ketoconazole Price Index remained stable quarter-over-quarter, influenced by mixed macroeconomic signals in Q3 2025.
- Ketoconazole production costs faced upward pressure from elevated natural gas and overall raw material costs throughout Q3 2025.
- The Producer Price Index declined 1.7% year-over-year in September 2025, slightly easing overall manufacturing expenses.
- Demand for Ketoconazole was supported by a surge in German pharmaceutical production in July 2025 and European market expansion.
- The Consumer Price Index rose 2.4% year-over-year in September 2025, indicating inflationary pressures impacting consumer purchasing power.
- The Manufacturing Index showed a contracting trend in September 2025, signaling a slowdown in the broader German manufacturing sector.
- Industrial production contracted 1.0% year-over-year in September 2025, reflecting weaker industrial demand for chemical inputs.
- Ketoconazole price forecast suggests stability, balancing easing producer costs with persistent energy and raw material expenses.
Why did the price of Ketoconazole change in September 2025 in Europe?
- The Producer Price Index declined 1.7% year-over-year in September 2025, reducing manufacturing input costs.
- Natural gas and overall raw material costs remained elevated in Q3 2025, maintaining upward pressure on production.
- German pharmaceutical production surged in July 2025, boosting demand for Ketoconazole active pharmaceutical ingredient.
